Rick J. D'Augustine
Director/Board Member at Ischemia Care LLC
Profile
Mr. D'Augustine is an Advisor for Spring Mill Venture Partners.
Since 1999 he has been President, CEO and a Director of UMD, Inc., a venture-backed drug delivery company focusing on women's health issues.
Just prior to joining UMD, he spent five years as a group director at Senmed Medical Ventures, a private medical venture capital and business development firm.
Earlier in his career, he spent sixteen years with Johnson and Johnson.
Mr. D'Augustine was a founding board member of Ethicon Endo-Surgery, initially serving as Vice President of Administration and CFO.
He was a founding board member of Enable Medical Corp., a private, high-technology medical device company.
He was also a founding board member of Atricure, Inc., an Enable spin-off focused on surgically treating atrial fibrillation that is now a public company.
He also recently served on the Board of Directors at endoVia Medical, Inc., a venture-backed surgical robotics company that was sold to Hansen Medical prior to their public offering in 2006.
In addition to his role at UMD, Inc., he also currently serves as Chairman of the Board of SpineForm LLC, which is developing a spinal implant system to treat progressive scoliosis.
Mr. D'Augustine has a Bachelor of Science Degree in Mechanical Engineering from Rensselaer Polytechnic Institute and an MBA in Finance from Seton Hall University.
Rick J. D'Augustine active positions
| Companies | Position | Start |
|---|---|---|
Spring Mill Venture Partners
 Spring Mill Venture Partners Investment ManagersFinance Spring Mill Venture Partners (Spring Mill) is a venture capital firm founded in 2004 by Ken Green, Jane H. Martin and David O. Mann. The firm is headquartered in Carmel, Indiana. | Consultant / Advisor | - |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Director/Board Member | 31/12/2011 |
Ischemia Care LLC
 Ischemia Care LLC Medical/Nursing ServicesHealth Services Ischemia Care LLC engages in the provision of diagnostic development, laboratory testing, precision medicine, and bioinformatics. The company was founded by Jeffrey June in 2009 and is headquartered in Middletown, OH. | Director/Board Member | 31/12/2010 |
Blue Ash Therapeutics LLC
 Blue Ash Therapeutics LLC BiotechnologyHealth Technology Blue Ash Therapeutics LLC was formed in December 2008 in Cincinnati to bring a promising cardiovascular drug - azimilide - to market. Azimilide is an oral once-daily cardiac ant arrhythmic (AA) drug for use in patients whose life-threatening arrhythmias require an implantable cardioverter-defibrillator (ICD) as a therapy of last resort. Azimilide became available for license upon Procter and Gamble's strategic exit in 2008 and final sell-off of pharmaceuticals assets to Warner Chilcott in October 2009. Blue Ash Therapeutics was formed by former P&G managers with long experience and extensive knowledge of azimilide and what's needed for its approval and market launch. In the first 13 months of its formation Blue Ash Therapeutics has assembled public and private seed-round investments, has been awarded a Third Frontier (GCIC) funding grant, and has secured global License Agreement with current azimilide owners, Warner Chilcott, PLC. The next major phase for Blue Ash Therapeutics will be securing venture-funding for carrying out a final FDA-required clinical trial of azimilide for marketing approval. Blue Ash Therapeutics seeks to commercialize not only azimilide, but to grow into a Cincinnati-based company specializing in acute-care cardiovascular therapies. | Director/Board Member | 31/12/2008 |
Former positions of Rick J. D'Augustine
| Companies | Position | End |
|---|---|---|
Enable Medical Corp.
 Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Director/Board Member | 31/12/2004 |
| ATRICURE, INC. | Director/Board Member | 31/12/2001 |
| Senmed Medical Ventures | Private Equity Investor | 30/11/1998 |
Ethicon Endo-Surgery, Inc.
 Ethicon Endo-Surgery, Inc. Medical SpecialtiesHealth Technology Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH. | Director/Board Member | 30/06/1993 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Rick J. D'Augustine
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Seton Hall University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ATRICURE, INC. | Health Technology |
| Private companies | 10 |
|---|---|
SpineForm LLC
 SpineForm LLC Medical DistributorsDistribution Services SpineForm LLC is a biomedical company, which engages in the development of spinal deformity treatment products. It offers spine staple, a product that treats curvature of the spine known as scoliosis. The company was founded by Dr. Eric J. Wall and Dr. Donita I. Bylski-Austrow in November 2004 and is headquartered in Cincinnati, OH. | Distribution Services |
Ethicon Endo-Surgery, Inc.
Ethicon Endo-Surgery, Inc. Medical SpecialtiesHealth Technology Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH. | Health Technology |
endoVia Medical, Inc.
 endoVia Medical, Inc. Medical SpecialtiesHealth Technology endoVia Medical, Inc. used to develop surgical medical products. The company was founded in 1996 and is headquartered in Norwood, MA. | Health Technology |
Enable Medical Corp.
Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Health Technology |
| Senmed Medical Ventures | Finance |
Spring Mill Venture Partners
Spring Mill Venture Partners Investment ManagersFinance Spring Mill Venture Partners (Spring Mill) is a venture capital firm founded in 2004 by Ken Green, Jane H. Martin and David O. Mann. The firm is headquartered in Carmel, Indiana. | Finance |
UMD, Inc.
 UMD, Inc. Pharmaceuticals: MajorHealth Technology UMD, Inc. develops drug delivery systems and technologies. Its products are tampon-based formulation of a non-steroidal anti-inflammatory drug for the treatment of dysmenorrhea. The company was founded by Donald C. Harrison in 1997 and is headquartered in Cincinnati, OH. | Health Technology |
Blue Ash Therapeutics LLC
Blue Ash Therapeutics LLC BiotechnologyHealth Technology Blue Ash Therapeutics LLC was formed in December 2008 in Cincinnati to bring a promising cardiovascular drug - azimilide - to market. Azimilide is an oral once-daily cardiac ant arrhythmic (AA) drug for use in patients whose life-threatening arrhythmias require an implantable cardioverter-defibrillator (ICD) as a therapy of last resort. Azimilide became available for license upon Procter and Gamble's strategic exit in 2008 and final sell-off of pharmaceuticals assets to Warner Chilcott in October 2009. Blue Ash Therapeutics was formed by former P&G managers with long experience and extensive knowledge of azimilide and what's needed for its approval and market launch. In the first 13 months of its formation Blue Ash Therapeutics has assembled public and private seed-round investments, has been awarded a Third Frontier (GCIC) funding grant, and has secured global License Agreement with current azimilide owners, Warner Chilcott, PLC. The next major phase for Blue Ash Therapeutics will be securing venture-funding for carrying out a final FDA-required clinical trial of azimilide for marketing approval. Blue Ash Therapeutics seeks to commercialize not only azimilide, but to grow into a Cincinnati-based company specializing in acute-care cardiovascular therapies. | Health Technology |
Ischemia Care LLC
Ischemia Care LLC Medical/Nursing ServicesHealth Services Ischemia Care LLC engages in the provision of diagnostic development, laboratory testing, precision medicine, and bioinformatics. The company was founded by Jeffrey June in 2009 and is headquartered in Middletown, OH. | Health Services |
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
- Stock Market
- Insiders
- Rick J. D'Augustine
